Behavioral Activation Therapy for Depression After Respiratory Failure
(BEHAB Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to assist individuals who have survived serious breathing problems in the ICU and now face depression and physical challenges. The treatment, called Behavioral Activation - Rehabilitation, combines therapy for depression with physical rehabilitation, delivered through phone calls and home visits. The goal is to determine if this approach is practical and can enhance recovery. Suitable participants include those who were on life support in the ICU and now experience at least mild depression. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could improve recovery strategies for ICU survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this therapy is safe for patients recovering from respiratory failure?
Research has shown that Behavioral Activation - Rehabilitation is generally well-tolerated by individuals who have recovered from respiratory failure. This treatment aims to enhance mood and physical abilities by addressing mental and physical health needs simultaneously. While specific data on side effects for this treatment is limited, similar therapies have demonstrated good results for depression with few side effects. Additionally, since this trial is not in its early stages, previous research likely indicates that the treatment is safe enough for further testing. This information should reassure those considering participation in the trial.12345
Why are researchers excited about this trial?
Researchers are excited about Behavioral Activation Therapy for depression after respiratory failure because it offers a new approach by focusing on engaging patients in meaningful activities to improve mood, rather than relying solely on medication. While standard treatments for depression typically involve antidepressants or talk therapy, this method empowers patients to take an active role in their recovery. This therapy can be particularly beneficial for those who may not respond well to medication or prefer a non-pharmacological approach. By targeting behavior and activity levels, it aims to break the cycle of inactivity and depressive symptoms, potentially offering quicker and more sustainable improvements in mood.
What evidence suggests that Behavioral Activation - Rehabilitation might be an effective treatment for depression after respiratory failure?
Research has shown that Behavioral Activation Therapy, which participants in this trial may receive, effectively treats depression. It encourages activities that improve mood, particularly benefiting those recovering from breathing problems. Studies have found that combining this therapy with physical rehabilitation addresses both mental and physical issues, leading to better overall recovery. For patients experiencing depression after breathing difficulties, this therapy could enhance both mental health and physical abilities. Early results suggest it is a promising method for managing these combined challenges.12345
Who Is on the Research Team?
Ann M Parker, MD
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
This trial is for adults over 18 who were living at home before ICU admission, experienced acute respiratory failure requiring intensive care for more than 24 hours, and have mild depressive symptoms. Excluded are those with long ICU stays, substance abuse or psychosis, severe prior disability, non-English speakers, homelessness or living far from the study site.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Behavioral Activation and physical rehabilitation via telephone and 2 home visits over 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Behavioral Activation - Rehabilitation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator